Hepion Capex To Depreciation vs Pocfratio Analysis

HEPA Stock  USD 0.63  0.02  3.28%   
Hepion Pharmaceuticals financial indicator trend analysis is much more than just examining Hepion Pharmaceuticals latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Hepion Pharmaceuticals is a good investment. Please check the relationship between Hepion Pharmaceuticals Capex To Depreciation and its Pocfratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.

Capex To Depreciation vs Pocfratio

Capex To Depreciation vs Pocfratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Hepion Pharmaceuticals Capex To Depreciation account and Pocfratio. At this time, the significance of the direction appears to have pay attention.
The correlation between Hepion Pharmaceuticals' Capex To Depreciation and Pocfratio is -0.8. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Pocfratio in the same time period over historical financial statements of Hepion Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Hepion Pharmaceuticals' Capex To Depreciation and Pocfratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Hepion Pharmaceuticals are associated (or correlated) with its Pocfratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pocfratio has no effect on the direction of Capex To Depreciation i.e., Hepion Pharmaceuticals' Capex To Depreciation and Pocfratio go up and down completely randomly.

Correlation Coefficient

-0.8
Relationship DirectionNegative 
Relationship StrengthSignificant

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Pocfratio

Most indicators from Hepion Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hepion Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.At present, Hepion Pharmaceuticals' Enterprise Value Over EBITDA is projected to increase based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.04, whereas Selling General Administrative is forecasted to decline to about 6.5 M.

Hepion Pharmaceuticals fundamental ratios Correlations

0.840.860.98-0.99-0.580.561.01.00.590.640.060.750.611.00.70.90.580.520.590.120.70.920.450.11-0.7
0.840.870.81-0.84-0.70.440.840.840.750.830.090.80.640.860.670.860.640.220.34-0.150.770.950.09-0.04-0.67
0.860.870.79-0.83-0.760.810.840.840.750.730.330.830.850.850.650.860.540.340.580.210.810.880.180.11-0.73
0.980.810.79-0.99-0.460.470.990.980.460.55-0.070.650.50.980.70.860.520.510.570.080.590.890.480.07-0.63
-0.99-0.84-0.83-0.990.53-0.53-1.0-1.0-0.55-0.61-0.01-0.7-0.57-1.0-0.72-0.88-0.54-0.48-0.55-0.06-0.65-0.92-0.43-0.050.65
-0.58-0.7-0.76-0.460.53-0.56-0.56-0.57-0.84-0.9-0.34-0.97-0.7-0.57-0.19-0.8-0.76-0.43-0.27-0.09-0.98-0.7-0.17-0.180.86
0.560.440.810.47-0.53-0.560.530.530.560.420.520.560.810.540.470.530.260.330.550.460.580.510.180.07-0.45
1.00.840.840.99-1.0-0.560.531.00.580.650.020.730.581.00.70.880.570.50.540.060.690.930.430.06-0.67
1.00.840.840.98-1.0-0.570.531.00.590.650.020.740.581.00.690.880.570.50.540.060.690.930.430.06-0.67
0.590.750.750.46-0.55-0.840.560.580.590.850.440.840.740.590.520.630.540.110.17-0.050.850.69-0.130.13-0.6
0.640.830.730.55-0.61-0.90.420.650.650.850.120.920.570.660.280.770.720.230.03-0.290.940.83-0.01-0.14-0.69
0.060.090.33-0.07-0.01-0.340.520.020.020.440.120.250.770.020.210.120.160.110.380.50.27-0.01-0.020.35-0.25
0.750.80.830.65-0.7-0.970.560.730.740.840.920.250.70.740.330.890.790.50.360.080.990.820.270.17-0.9
0.610.640.850.5-0.57-0.70.810.580.580.740.570.770.70.580.550.650.460.30.610.430.70.590.120.28-0.64
1.00.860.850.98-1.0-0.570.541.01.00.590.660.020.740.580.690.890.570.490.530.050.70.940.420.05-0.67
0.70.670.650.7-0.72-0.190.470.70.690.520.280.210.330.550.690.450.110.050.490.120.280.630.050.13-0.25
0.90.860.860.86-0.88-0.80.530.880.880.630.770.120.890.650.890.450.820.650.540.130.850.90.510.14-0.9
0.580.640.540.52-0.54-0.760.260.570.570.540.720.160.790.460.570.110.820.70.330.040.780.610.530.08-0.8
0.520.220.340.51-0.48-0.430.330.50.50.110.230.110.50.30.490.050.650.70.60.480.460.330.950.3-0.69
0.590.340.580.57-0.55-0.270.550.540.540.170.030.380.360.610.530.490.540.330.60.830.290.330.60.65-0.6
0.12-0.150.210.08-0.06-0.090.460.060.06-0.05-0.290.50.080.430.050.120.130.040.480.830.04-0.160.480.76-0.37
0.70.770.810.59-0.65-0.980.580.690.690.850.940.270.990.70.70.280.850.780.460.290.040.790.210.1-0.86
0.920.950.880.89-0.92-0.70.510.930.930.690.83-0.010.820.590.940.630.90.610.330.33-0.160.790.22-0.13-0.68
0.450.090.180.48-0.43-0.170.180.430.43-0.13-0.01-0.020.270.120.420.050.510.530.950.60.480.210.220.26-0.52
0.11-0.040.110.07-0.05-0.180.070.060.060.13-0.140.350.170.280.050.130.140.080.30.650.760.1-0.130.26-0.46
-0.7-0.67-0.73-0.630.650.86-0.45-0.67-0.67-0.6-0.69-0.25-0.9-0.64-0.67-0.25-0.9-0.8-0.69-0.6-0.37-0.86-0.68-0.52-0.46
Click cells to compare fundamentals

Hepion Pharmaceuticals Account Relationship Matchups

Hepion Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets20.6M48.6M103.6M60.2M18.1M27.5M
Other Current Liab851.2K342.6K5.2M5.1M2.7M1.8M
Total Current Liabilities1.6M4.7M8.2M7.9M5.3M3.8M
Total Stockholder Equity15.6M40.5M93.0M49.9M7.3M6.9M
Net Debt(13.1M)(40.0M)(91.0M)(51.1M)(14.6M)(15.3M)
Retained Earnings(83.8M)(104.1M)(133.5M)(175.7M)(224.6M)(213.4M)
Accounts Payable491.6K3.7M2.4M2.7M2.3M2.0M
Cash13.9M40.7M91.3M51.2M14.8M22.3M
Cash And Short Term Investments13.9M40.7M91.3M51.2M14.8M24.2M
Common Stock Total Equity1.7K375.03.2K7.6K8.8K9.2K
Common Stock Shares Outstanding102.2K483.9K3.5M3.8M4.0M4.2M
Liabilities And Stockholders Equity20.6M48.6M103.6M60.2M18.1M27.5M
Non Current Liabilities Total3.4M3.5M2.4M2.5M5.5M4.0M
Other Stockholder Equity97.7M142.9M224.8M223.9M230.3M241.8M
Total Liab5.0M8.1M10.6M10.4M10.8M7.7M
Total Current Assets14.4M42.6M97.5M56.5M17.5M24.0M
Common Stock25.0375.03.2K7.6K482.0457.9
Non Currrent Assets Other306.9K285.1K583.3K426.2K364.2K228.6K
Property Plant And Equipment Gross855.1K108.4K696.7K439.2K621.8K652.9K
Property Plant And Equipment Net855.1K664.9K456.5K132.2K242.4K289.1K
Non Current Assets Total6.2M6.0M6.1M3.7M606.6K576.2K
Other Assets3.3M4.0M583.3K426.2K490.1K465.6K
Capital Surpluse76.7M97.7M142.9M223.9M257.5M270.4M
Other Current Assets465.7K1.9M6.1M5.3M2.7M2.0M
Property Plant Equipment855.1K664.9K456.5K81.6K93.9K89.2K
Short Long Term Debt Total807.4K752.2K317.0K53.6K209.0K360.0K
Other Liab2.5M3.0M2.3M2.5M2.3M3.2M
Net Tangible Assets12.6M36.9M86.2M45.0M51.7M54.3M
Non Current Liabilities Other2.4M2.6M1.9M2.1M1.6M2.0M
Net Invested Capital14.5M39.0M91.3M48.2M5.6M5.3M
Net Working Capital13.1M38.0M89.2M48.6M12.2M11.6M
Short Term Debt266.7K559.7K533.3K107.2K231.8K359.9K
Capital Stock1.7M1.7M1.7M1.7M1.7M1.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Hepion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hepion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hepion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hepion Pharmaceuticals Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hepion Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
For information on how to trade Hepion Stock refer to our How to Trade Hepion Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hepion Pharmaceuticals. If investors know Hepion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hepion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.40)
Return On Assets
(0.93)
Return On Equity
(1.90)
The market value of Hepion Pharmaceuticals is measured differently than its book value, which is the value of Hepion that is recorded on the company's balance sheet. Investors also form their own opinion of Hepion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Hepion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hepion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Hepion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hepion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hepion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hepion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.